Laboratory Analyzer segment has the Largest Share of Product Type in the South and Central America Hemostasis Analyzers Market during 2020–2028 

According to a new market research study on “South and Central America Hemostasis Analyzers Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product Type, Test, End User and Country” is expected to reach US$ 381.49 million by 2028 from US$ 212.02 million in 2021. The market is estimated to grow at a CAGR of 8.8% from 2021 to 2028. The report provides trends prevailing in the South and Central America hemostasis analyzers market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to rising number of cardiovascular diseases and rise in the geriatric population are the key factors driving the market growth. However, the market is expected to experience slow growth during the forecast period owing to high cost of fully automated hemostasis analyzer.

The outbreak of COVID–19 has stringently affected medical services in the South and Central America region. Also, the nations are famous for medical tourism, which is also influenced by the pandemic. The second wave of COVID19 has affected Brazil, Argentina, Uruguay, Chile, Peru, and Colombia. It is anticipated that the region will likely impose a lockdown due to the emerging risk of the new COVID19 variant omicron, which is expected to increase the rate of infection, which will eventually hamper the healthcare industry in the area. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is concerned by the third wave of COVID19 infection. Amongst which Brazil has registered the majority of the deaths. It is anticipated that the region will likely force a second lockdown, which will ultimately hamper the healthcare industry in the area.

The market for South and Central America Hemostasis Analyzers Market is segmented into the product type, test, end user and country. Based on product type, the South and Central America Hemostasis Analyzers Market is segmented into laboratory analyzer, and point-of-care testing systems, whereas laboratory analyzer sub segmented   into automated systems, semi-automated systems, and manual systems. In 2021, the laboratory analyzer segment accounted for the largest market share. The growth of these segments is attributed to an increase in the prevalence of chronic illnesses like blood disorders and cardiovascular diseases, development of point of care (POC) coagulation testing, and the surge in laboratory automation is likely to create opportunity in the forecast year. However the point-of-care testing systems segment is estimated to register the highest CAGR during the forecast period.

Siemens Healthineers AG , Abbott  , Sysmex Corporation , Nihon Kohden Corporation ,THERMO FISHER SCIENTIFIC INC. ,HOFFMANN-LA ROCHE LTD. , Instrumentation Laboratory Company. Among the leading companies in the South and Central America hemostasis analyzers market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.

The market for South and Central America hemostasis analyzers market is segmented into product type, test, and end user. Based on product type, the South and Central America hemostasis analyzers market is segmented into laboratory analyzer [automated systems, semi-automated systems, and manual systems], and point-of-care testing systems. Based on test, the South and Central America hemostasis analyzers market is segmented into activated partial thromboplastin time, d-dimer test, fibrinogen test, prothrombin time (PT) test, and others. Based on end user, the South and Central America hemostasis analyzers market is segmented into hospitals/ clinics, independent diagnostic laboratories, home care setting, and others. By Geographically, South and Central America hemostasis analyzers market is segmented into (Brazil, Argentina and Rest of South and Central America).

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com